Arcellx News

Buy Rating Backed by Potential Regulatory Tailwinds for Arcellx's CAR-T Therapy

TipRanksApr 12 01:35 ET

Arcellx Analyst Ratings

BenzingaApr 11 06:12 ET

Optimizing Investment Decisions: Unveiling the Buy Rating for Arcellx Inc.

TipRanksApr 11 05:56 ET

Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX) and Adaptive Biotechnologies (ADPT)

TipRanksApr 4 07:10 ET

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Arcellx Inc (ACLX) and AdaptHealth (AHCO)

TipRanksMar 18 07:10 ET

Arcellx Analyst Ratings

BenzingaMar 18 07:07 ET

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Arcellx Inc (ACLX) and Exact Sciences (EXAS)

TipRanksMar 15 01:42 ET

Arcellx Analyst Ratings

BenzingaMar 14 12:38 ET

Stifel Reiterates Buy on Arcellx, Maintains $82 Price Target

BenzingaMar 14 12:40 ET

Analysts Are Bullish on Top Healthcare Stocks: Silk Road Medical (SILK), Arcellx Inc (ACLX)

TipRanksMar 14 08:40 ET

Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Ionis Pharmaceuticals (IONS) and Arcellx Inc (ACLX)

TipRanksMar 14 05:50 ET

Arcellx Analyst Ratings

BenzingaMar 7 03:54 ET

Arcellx Analyst Ratings

BenzingaMar 5 10:16 ET

Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Astria Therapeutics (ATXS)

TipRanksMar 5 07:31 ET

Arcellx Analyst Ratings

BenzingaFeb 29 15:25 ET

Barclays Adjusts Arcellx's Price Target to $73 From $62, Keeps Overweight Rating

MT NewswiresFeb 29 12:26 ET

Buy Rating Affirmed for Arcellx Inc's Anito-cel Amid Superior Safety Profile and Strong Market Entry Prospects

TipRanksFeb 29 10:05 ET

Anticipating Arcellx Inc. Catalysts: Strong CAR-T Trial Data Underpin Buy Rating

TipRanksFeb 29 06:25 ET

Strong Buy Rating for Arcellx Inc. on Robust Financials and Promising Clinical Milestones

TipRanksFeb 29 05:37 ET

Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX), Sarepta Therapeutics (SRPT) and AptarGroup (ATR)

TipRanksFeb 29 05:30 ET